🇺🇸 Engerix B Hepatitis B Vaccine in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 10
Most-reported reactions
- Abdominal Discomfort — 1 report (10%)
- Abortion Induced — 1 report (10%)
- Abortion Spontaneous — 1 report (10%)
- Acute Kidney Injury — 1 report (10%)
- Acute Myocardial Infarction — 1 report (10%)
- Anxiety — 1 report (10%)
- Appetite Disorder — 1 report (10%)
- Blood Pressure Increased — 1 report (10%)
- Brain Fog — 1 report (10%)
- Deep Vein Thrombosis — 1 report (10%)
Other Immunology approved in United States
Frequently asked questions
Is Engerix B Hepatitis B Vaccine approved in United States?
Engerix B Hepatitis B Vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Engerix B Hepatitis B Vaccine in United States?
Tel-Aviv Sourasky Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.